|
|
Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy.
Roch Houot
,
Holbrook E. Kohrt
,
Aurélien Marabelle
,
Ronald Levy
Journal articles
istex
hal-00744044v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
(18)F-FDG PET and CT-scan Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-PD1 Immune Checkpoint Inhibitor.
Laurent Dercle
,
Romain-David Seban
,
Julien Lazarovici
,
Lawrence Schwartz
,
Roch Houot
et al.
Journal articles
hal-01567811v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Holbrook Kohrt: In Memoriam (1977-2016)
Roch Houot
,
Russell Pachynski
,
Debra K. Czerwinski
,
Matthew J. Goldstein
,
Idit Sagiv-Barfi
et al.
Journal articles
hal-01373905v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hyperprogression upon immunotherapy: A chance for (hyper-)progress
Roch Houot
,
Aurélien Marabelle
,
Stéphane Champiat
Journal articles
hal-03228894v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CAR-T cells and BiTEs in solid tumors: challenges and perspectives
Julien Edeline
,
Roch Houot
,
Aurélien Marabelle
,
Marion Alcantara
Journal articles
hal-03228682v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hair Repigmentation With Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis
Guillaume Manson
,
Aurélien Marabelle
,
Roch Houot
Journal articles
hal-01699247v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genomic Instability and Pro-Tumoral Inflammation are associated with Primary Resistance to Anti-PD1 + Anti-Angiogenesis in Malignant Pleural Mesothelioma
Francois-Xavier Danlos
,
Matthieu Texier
,
Bastien Job
,
Severine Mouraud
,
Lydie Cassard
et al.
Journal articles
hal-03972355v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie De Charette
,
Aurélien Marabelle
,
Roch Houot
Journal articles
hal-01416159v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|